You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine

Article metrics

Article menu

Download PDFPDF

Research Article
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 2020551
Feb 2020883
Mar 202016161
Apr 202013130
May 202019196
Jun 2020992
Jul 202012121
Aug 2020992
Sep 202026264
Oct 202026264
Nov 202014142
Dec 2020665
Jan 202111111
Feb 2021993
Mar 202110102
Apr 2021663
May 2021221
Jun 202116162
Jul 202115155
Aug 2021441
Sep 2021666
Oct 202110106
Nov 202115156
Dec 202119196
Jan 202214150
Feb 202216166
Mar 202214142
Apr 202215162
May 202224241
Jun 202232326
Jul 202223267
Aug 202243434
Sep 2022303018
Oct 202233358
Nov 2022296511
Dec 202210205
Jan 202313135
Feb 202322220
Mar 202314147
Apr 2023999
May 2023664
Jun 2023884
Jul 2023889
Aug 2023773
Sep 20231171174
Oct 202318186
Nov 2023885
Dec 202321215
Jan 202410115
Feb 202414146
Mar 2024181830
Total864918245